Gene: ARRDC2
Official Full Name: arrestin domain containing 2provided by HGNC
Gene Summary: Predicted to be involved in protein transport. Located in cytoplasmic vesicle and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27833 | ARRDC2 Knockout cell line (HeLa) | Human | ARRDC2 | 1:3~1:6 | Negative | Online Inquiry |
KO27834 | ARRDC2 Knockout cell line (HCT 116) | Human | ARRDC2 | 1:2~1:4 | Negative | Online Inquiry |
KO27835 | ARRDC2 Knockout cell line (HEK293) | Human | ARRDC2 | 1:3~1:6 | Negative | Online Inquiry |
KO27836 | ARRDC2 Knockout cell line (A549) | Human | ARRDC2 | 1:3~1:4 | Negative | Online Inquiry |
ARRDC2 Gene Knockout Cell Lines are specialized cellular models engineered to express a complete absence of the ARRDC2 gene, a regulator implicated in various physiological processes, including cell signaling and protein trafficking. These cell lines are invaluable tools for researchers aiming to dissect the specific functions of ARRDC2 in cellular contexts, providing insights into its role in diseases such as cancer and metabolic disorders.
The key functions of ARRDC2 are implicated in modulating receptor-mediated endocytosis and influencing post-translational modifications of proteins. With the knockout of ARRDC2, researchers can observe the resultant impact on cellular behaviors, including proliferation, differentiation, and response to external stimuli. These cell lines facilitate in vitro studies that elucidate molecular mechanisms, thereby advancing our understanding of biological pathways and disease mechanisms.
The scientific importance of ARRDC2 Gene Knockout Cell Lines extends into clinical research, specifically in drug development and therapeutic targeting. Their ability to mimic the absence of a specific gene allows for a controlled environment to evaluate the efficacy and toxicity of novel compounds. As such, they are pivotal in developing targeted therapies, wherein understanding the exact role of ARRDC2 can lead to tailored treatment approaches.
Compared to alternative models, these knockout lines offer a distinct advantage by providing a clean genetic background devoid of confounding factors, ensuring that observed phenotypic changes can be directly attributed to the lack of ARRDC2. Unlike conventional cell lines that may possess varying levels of gene expression, our ARRDC2 knockout lines ensure reproducibility and reliability in experimental outcomes.
For researchers and clinicians, the availability of ARRDC2 Gene Knockout Cell Lines represents an essential advancement in the toolbox available for biological and medical research. They empower scientists to explore fundamental questions regarding cell biology and disease pathology, ultimately driving innovation and discovery. Our company prides itself on a commitment to excellence and innovation in the field of biological products, continuously offering state-of-the-art tools that enhance research capabilities and foster scientific breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.